Erythema Elevatum Diutinum in Association with IgA Monoclonal Gammopathy of Undetermined Significance A Case Report
Main Article Content
Keywords
diagnostic challenges, small vessel vasculitis, iga monoclonal gammopathy, leukocytoclastic vasculitis, erythema elevatum diutinum (eed)
Abstract
Erythema Elevatum Diutinum (EED) is a distinctive form of chronic leukocytoclastic vasculitis characterized by red to brown papules, plaques, and nodules that favor the extensor aspect of the extremities. EED is a benign condition but may be associated with several systemic diseases, including hematologic disorders, infections, and autoimmune conditions. EED is a rare entity of vasculitis, with less than 400 cases being reported in world literature to date. We present a rare case of a 61-year-old male with IgA monoclonal gammopathy of undetermined significance (MGUS) and a 17-year history of EED that improved significantly with dapsone treatment.
References
2. Rashdan H, Schafer H, Lundgren AD, O'Connor K, Keeling B: Transient Erythema Elevatum Diutinum Associated With HIV Viremia. Cureus. 2023156, 40858-2023. 10.7759/cureus.40858
3. Patnala GP, Sunandini AP, Rayavarapu R, Yandapalli PS: Erythema elevatum diutinum in association with IgAmonoclonalgammopathy:Ararecasereport.IndianDermatolOnlineJ.2016,7:300-303. 10.4103/2229- 5178.185472
4. James A. Yiannias, MD, Rokea A. El-Azhary, MD, Lawrence E. Gibson, MD : Erythema elevatum diutinum: A clinical and histopathologic study of 13 patients. Journal of the American Academy of Dermatology. 1992, 26:38-44. 10.1016/0190-9622(92)70003-X
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.